Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase

Human Molecular Genetics

Volumn 24, Issue 25, 2015, Pages 7390-7405

  Henriques, Alexandre ^a,b   Croixmarie, Vincent ^c   Priestman, David A ^d   Rosenbohm, Angela ^e   Dirrig Grosch, Sylvie ^a,b   D'Ambra, Eleonora ^a,b   Huebecker, Mylene ^d   Hussain, Ghulam ^a,b,f   Boursier Neyret, Claire ^c   Echaniz Laguna, Andoni ^a,b,g   Ludolph, Albert C ^e   Platt, Frances M ^d   Walther, Bernard ^c   Spedding, Michael ^c,h   Loeffler, Jean Philippe ^a,b   De Aguilar, Jose Luis Gonzalez ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Laboratoire des Mecanismes Centraux et Peripheriques de la Neurodegenerescence   (France)

^c INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF ULM   (Germany)

^f GC UNIVERSITY   (Pakistan)

^g UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^h SPEDDING RESEARCH SOLUTIONS SARL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; GLUCOSYLCERAMIDE; GLYCOSPHINGOLIPID; SPHINGOLIPID; GLUCOSYLTRANSFERASE;

AEROBIC METABOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE DENERVATION; MUSCLE STRENGTH; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; ANIMAL; ELECTROMYOGRAPHY; GENETICS; METABOLISM; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROMYOGRAPHY; GLUCOSYLTRANSFERASES; HUMANS; MALE; MICE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOLIPIDS;

EID: 84959195588     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv439     Document Type: Article

References (64)

1. Kiernan, M.C., Vucic, S., Cheah, B.C., Turner, M.R., Eisen, A., Hardiman, O., Burrell, J.R. and Zoing, M.C. (2011) Amyotrophic lateral sclerosis. Lancet, 377, 942-955.
2. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P., Deng, H. X. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
3. Renton, A.E., Chiò, A. and Traynor, B.J. (2014) State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci., 17, 17-23.
4. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H. X. et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772-5.
5. Ripps, M.E., Huntley, G.W., Hof, P.R., Morrison, J.H. and Gordon, J.W. (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 92, 689-693.
6. Wong, P.C., Pardo, C.A., Borchelt, D.R., Lee, M.K., Copeland, N. G., Jenkins, N.A., Sisodia, S.S., Cleveland, D.W. and Price, D.L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14, 1105-1116.
7. Desport, J.C., Torny, F., Lacoste, M., Preux, P.M. and Couratier, P. (2005) Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener. Dis., 2, 202-207.
8. Dupuis, L., Pradat, P.F., Ludolph, A.C. and Loeffler, J.P. (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol., 10, 75-82.
9. Schmitt, F., Hussain, G., Dupuis, L., Loeffler, J.P. and Henriques, A. (2014) A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front. Cell. Neurosci., 8, 25.
10. Dupuis, L., Oudart, H., René, F., Gonzalez De Aguilar, J.L. and Loeffler, J.P. (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl Acad. Sci. USA, 101, 11159-11164.
11. Fergani, A., Oudart, H., Gonzalez DeAguilar, J.L., Fricker, B., René, F., Hocquette, J.F., Meininger, V., Dupuis, L. and Loeffler, J.P. (2007) Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res., 48, 1571-1580.
12. Palamiuc, L., Schlagowski, A., Ngo, S.T., Vernay, A., Dirrig-Grosch, S., Henriques, A., Boutillier, A.L., Zoll, J., Echaniz-Laguna, A., Loeffler, J.P. and René, F. (2015) A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med., 7, 526-546.
13. Dupuis, L., Corcia, P., Fergani, A., Gonzalez De Aguilar, J.L., Bonnefont-Rousselot, D., Bittar, R., Seilhean, D., Hauw, J.J., Lacomblez, L., Loeffler, J.P. and Meininger, V. (2008) Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology, 70, 1004-1009.
14. Dorst, J., Kühnlein, P., Hendrich, C., Kassubek, J., Sperfeld, A. D. and Ludolph, A.C. (2011) Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol., 258, 613-617.
15. Paganoni, S., Deng, J., Jaffa, M., Cudkowicz, M.E. and Wills, A. M. (2011) Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve, 44, 20-24.
16. Sutedja, N.A., van der Schouw, Y.T., Fischer, K., Sizoo, E.M., Huisman, M.H., Veldink, J.H. and Van den Berg, L.H. (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry, 82, 638-642.
17. Henriques, A., Blasco, H., Fleury, M.C., Corcia, P., Echaniz-Laguna, A., Robelin, L., Rudolf, G., Lequeu, T., Bergaentzle, M., Gachet, C. et al. (2015) Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis. PLoS One, 10, e0131512.
18. Cutler, R.G., Pedersen, W.A., Camandola, S., Rothstein, J.D. and Mattson, M.P. (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol., 52, 448-457.
19. Ilieva, E.V., Ayala, V., Jové, M., Dalfó, E., Cacabelos, D., Povedano, M., Bellmunt, M.J., Ferrer, I., Pamplona, R. and Portero-Otín, M. (2007) Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain, 130(Pt 12), 3111-3123.
20. Rozen, S., Cudkowicz, M.E., Bogdanov, M., Matson, W.R., Kristal, B.S., Beecher, C., Harrison, S., Vouros, P., Flarakos, J., Vigneau-Callahan, K. et al. (2005) Metabolomic analysis and signatures in motor neuron disease. Metabolomics, 1, 101-108.
21. Blasco, H., Corcia, P., Moreau, C., Veau, S., Fournier, C., Vourc'h, P., Emond, P., Gordon, P., Pradat, P.F., Praline, J. et al. (2010) 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE, 5, e13223.
22. Kumar, A., Bala, L., Kalita, J., Misra, U.K., Singh, R.L., Khetrapal, C.L. and Babu, G.N. (2010) Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clin. Chim. Acta, 411, 563-567.
23. Wuolikainen, A., Moritz, T., Marklund, S.L., Antti, H. and Andersen, P.M. (2011) Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLoS ONE, 6, e17947.
24. Lawton, K.A., Cudkowicz, M.E., Brown, M.V., Alexander, D., Caffrey, R., Wulff, J.E., Bowser, R., Lawson, R., Jaffa, M., Milburn, M.V. et al. (2012) Biochemical alterations associated with ALS. Amyotroph. Lateral Scler., 13, 110-118.
25. Wuolikainen, A., Andersen, P.M., Moritz, T., Marklund, S.L. and Antti, H. (2012) ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations. Mol. Genet. Metab., 105, 472-478.
26. Blasco, H., Corcia, P., Pradat, P.F., Bocca, C., Gordon, P.H., Veyrat-Durebex, C., Mavel, S., Nadal-Desbarats, L., Moreau, C., Devos, D. et al. (2013) Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J. Proteome Res., 12, 3746-3754.
27. Chan, E.C., Yap, S.L., Lau, A.J., Leow, P.C., Toh, D.F. and Koh, H. L. (2007) Ultra-performance liquid chromatography/time-offlight mass spectrometry based metabolomics of raw and steamed Panax notoginseng. Rapid Commun. Mass Spectrom., 21, 519-528.
28. Ishibashi, Y., Kohyama-Koganeya, A. and Hirabayashi, Y. (2013) New insights on glucosylated lipids: metabolism and functions. Biochim. Biophys. Acta, 1831, 1475-1485.
29. Wishart, D.S., Knox, C., Guo, A.C., Eisner, R., Young, N., Gautam, B., Hau, D.D., Psychogios, N., Dong, E., Bouatra, S. et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucl. Acids Res., 37, D603-D610.
30. Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z., Patti, G. and Siuzdak, G. (2012) An accelerated workflow for untargeted metabolomics using the METLIN database. Nature Biotechnol., 30, 826-828.
31. Kamburov, A., Pentchev, K., Galicka, H., Wierling, C., Lehrach, H. and Herwig, R. (2011) ConsensusPathDB: toward a more complete picture of cell biology. Nucl. Acids Res., 39, D712-D717.
32. Gonzalez De Aguilar, J.L., Niederhauser-Wiederkehr, C., Halter, B., De Tapia, M., Di Scala, F., Demougin, P., Dupuis, L., Primig, M., Meininger, V. and Loeffler, J.P. (2008) Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model. Physiol. Genomics, 32, 207-218.
33. Kamburov, A., Cavill, R., Ebbels, T.M., Herwig, R. and Keun, H. C. (2011) Integrated pathway-level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics, 27, 2917-2918.
34. Bruni, P. and Donati, C. (2008) Pleiotropic effects of sphingolipids in skeletal muscle. Cell. Mol. Life Sci., 65, 3725-3736.
35. Jennemann, R. and Gröne, H.J. (2013) Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis. Prog. Lipid Res., 52, 231-248.
36. Jasmin, B.J., Cartaud, J., Bornens, M. and Changeux, J.P. (1989) Golgi apparatus in chick skeletal muscle: changes in its distribution during end plate development and after denervation. Proc. Natl Acad. Sci. USA, 86, 7218-7222.
37. Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130-133.
38. Weihl, C.C., Temiz, P., Miller, S.E., Watts, G., Smith, C., Forman, M., Hanson, P.I., Kimonis, V. and Pestronk, A. (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry, 79, 1186-1189.
39. Cortese, A., Plagnol, V., Brady, S., Simone, R., Lashley, T., Acevedo-Arozena, A., de Silva, R., Greensmith, L., Holton, J., Hanna, M.G. et al. (2014) Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. Neurobiol. Aging, 35, 1491-1498.
40. Kilbey, A., Terry, A., Jenkins, A., Borland, G., Zhang, Q., Wakelam, M.J., Cameron, E.R. and Neil, J.C. (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res., 70, 5860-5869.
41. Lowrie, M.B., Krishnan, S. and Vrbová, G. (1982) Recovery of slow and fast muscles following nerve injury during early post-natal development in the rat. J. Physiol., 331, 51-66.
42. Navarrete, R. and Vrbová, G. (1984) Differential effect of nerve injury at birth on the activity pattern of reinnervated slow and fast muscles of the rat. J. Physiol., 351, 675-685.
43. Sharp, P.S., Dick, J.R. and Greensmith, L. (2005) The effect of peripheral nerve injury on disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience, 130, 897-910.
44. Aerts, J.M., Ottenhoff, R., Powlson, A.S., Grefhorst, A., van Eijk, M., Dubbelhuis, P.F., Aten, J., Kuipers, F., Serlie, M.J., Wennekes, T. et al. (2007) Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes, 56, 1341-1349.
45. Deumens, R., Jaken, R.J., Marcus, M.A. and Joosten, E.A. (2007) The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J. Neurosci. Methods, 164, 120-130.
46. Dodge, J.C., Treleaven, C.M., Pacheco, J., Cooper, S., Bao, C., Abraham, M., Cromwell, M., Sardi, S.P., Chuang, W.L., Sidman, R.L. et al. (2015) Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA, 112, 8100-8105.
47. Cuzner, M.L., Davison, A.N. and Gregson, N.A. (1965) The chemical composition of vertebrate myelin and microsomes. J. Neurochem., 12, 469-481.
48. Huang, F., Dong, X., Zhang, L., Zhang, X., Zhao, D., Bai, X. and Li, Z. (2009) The neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro. Brain Res. Bull., 79, 85-88.
49. Huang, F., Dong, X., Zhang, L., Zhang, X., Zhao, D., Bai, X. and Li, Z. (2010) GM1 and nerve growth factor modulate mitochondrial membrane potential and neurofilament light mRNA expression in cultured dorsal root ganglion and spinal cord neurons during excitotoxic glutamate exposure. J. Clin. Neurosci., 17, 495-500.
50. Leake, P.A., Hradek, G.T., Vollmer, M. and Rebscher, S.J. (2007) Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonates. J. Comp. Neurol., 501, 837-853.
51. Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jäger, R., Schorle, H., Kenzelmann, M. et al. (2005) Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc. Natl Acad. Sci. USA, 102, 12459-12464.
52. Chavez, J.A., Siddique, M.M., Wang, S.T., Ching, J., Shayman, J.A. and Summers, S.A. (2014) Ceramides and glucosylceramides are independent antagonists of insulin signaling. J. Biol. Chem., 289, 723-734.
53. Mason, R.R., Mokhtar, R., Matzaris, M., Selathurai, A., Kowalski, G.M., Mokbel, N., Meikle, P.J., Bruce, C.R. and Watt, M.J. (2014) PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle. Mol. Metab., 3, 652-663.
54. Kabayama, K., Sato, T., Saito, K., Loberto, N., Prinetti, A., Sonnino, S., Kinjo, M., Igarashi, Y. and Inokuchi, J. (2007) Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc. Natl Acad. Sci. USA, 104, 13678-13683.
55. Lombardo, E., van Roomen, C.P., van Puijvelde, G.H., Ottenhoff, R., van Eijk, M., Aten, J., Kuiper, J., Overkleeft, H.S., Groen, A.K., Verhoeven, A.J. et al. (2012) Correction of liver steatosis by a hydrophobic iminosugar modulating glycosphingolipids metabolism. PLoS One, 7, e38520.
56. Bandyopadhyay, U., Nagy, M., Fenton, W.A. and Horwich, A.L. (2014) Absence of lipofuscin in motor neurons of SOD1-linked ALS mice. Proc. Natl Acad. Sci. USA, 111, 11055-11060.
57. Guenther, G.G., Peralta, E.R., Rosales, K.R., Wong, S.Y., Siskind, L.J. and Edinger, A.L. (2008) Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc. Natl Acad. Sci. USA, 105, 17402-17407.
58. Guenther, G.G. and Edinger, A.L. (2009) A new take on ceramide: starving cells by cutting off the nutrient supply. Cell Cycle, 8, 1122-1126.
59. Halter, B., Gonzalez De Aguilar, J.L., Rene, F., Petri, S., Fricker, B., Echaniz-Laguna, A., Dupuis, L., Larmet, Y. and Loeffler, J.P. (2010) Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med., 48, 915-923.
60. Brooks, B.R., Miller, R.G., Swash, M. and Munsat, T.L., World Federation of Neurology Research Group on Motor Neuron Diseases. (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord., 1, 293-299.
61. Croixmarie, V., Umbdenstock, T., Cloarec, O., Moreau, A., Pascussi, J.M., Boursier-Neyret, C. and Walther, B. (2009) Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures. Anal. Chem., 81, 6061-6069.
62. Neville, D.C., Coquard, V., Priestman, D.A., te Vruchte, D.J., Sillence, D.J., Dwek, R.A., Platt, F.M. and Butters, T.D. (2004) Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem., 331, 275-282.
63. Kabashi, E., El Oussini, H., Bercier, V., Gros-Louis, F., Valdmanis, P.N., McDearmid, J., Mejier, I.A., Dion, P.A., Dupre, N., Hollinger, D. et al. (2013) Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum. Mol. Genet., 22, 2350-2360.
64. Werner, E., Croixmarie, V., Umbdenstock, T., Ezan, E., Chaminade, P., Tabet, J.C. and Junot, C. (2008) Mass spectrometrybased metabolomics: accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution. Anal. Chem., 80, 4918-4932.